Anders Bruun Mathiasen

Medicin og biovidenskab

1. Mesenchymal Stem Cells 100%
2. Myocardial Ischemia 71%
3. Stromal Cells 63%
4. Cell- and Tissue-Based Therapy 60%
5. Stem Cells 53%
6. Placebos 47%
7. Heart Failure 43%
8. Coronary Artery Disease 41%
9. Stroke Volume 36%
10. ST Elevation Myocardial Infarction 31%
11. Magnetic Resonance Imaging 29%
12. Injections 29%
13. Adipose Tissue 26%
14. Bone Marrow 24%
15. ferumoxtran-10 22%
16. Magnetic Resonance Spectroscopy 21%
17. Therapeutics 19%
18. Perfusion 17%
19. Safety 15%
20. Heart 15%
21. Nanoparticles 14%
22. Cardiology 13%
23. ferric oxide 12%
24. Rubidium-82 12%
25. Cardiovascular Diseases 12%
26. Vascular Endothelial Growth Factor A 12%
27. Biomarkers 11%
28. Blood Platelets 11%
29. Randomized Controlled Trials 10%
30. Left Atrial Function 10%
31. Infarction 10%
32. Gadolinium 10%
33. Percutaneous Coronary Intervention 10%
34. Tissue Donors 10%
35. Exercise 10%
36. Crowding 9%
37. Serum 9%
38. Exenatide 9%
39. Essential Thrombocythemia 9%
40. Clinical Studies 9%
41. Eagles 9%
42. Myocardium 9%
43. Polycythemia Vera 9%
44. Ischemia 9%
45. Primary Myelofibrosis 9%
46. Chromosomal Instability 8%
47. Cicatrix 8%
48. Trans-Activators 8%
49. Multidetector Computed Tomography 8%
50. Cardiac Myocytes 8%